Symbol Lookup

Friday March 06, 2015 9:04 AM ET. Data delayed 15 minutes.
10.56
0.00 (0.00%)
Bid/Lots
10.32/1
Ask/Lots
12.43/1
Open/Prev Close
0.00/10.56
Day Range
-----
52-Week Range
7.53-23.25
Vol/Avg Daily Vol
0.0/120.3K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
Analyst Actions: Cara Therapeutics Initiated With Buy And $26 Price Target At MLV & Co.
1:49PM ET on Tuesday Mar 03, 2015 by Midnight Trader
Companies Mentioned: CARA
01:49 PM EST, 03/03/2015 (MT Newswires) -- Cara Therapeutics (CARA) shares were initiated by MLV & Co. at buy and with a $26 price target as MLV expects the biopharmaceutical company to report positive results on Phase 2 and 3 studies in the next 12...
01:49 PM EST, 03/03/2015 (MT Newswires) -- Cara Therapeutics (CARA) shares were initiated by MLV & Co. at buy and with a $26 price target as MLV expects the biopharmaceutical company to report positive results on Phase 2 and 3 studies in the next...

Feb 10, 2015

Cara Therapeutics Issued Additional U.S. Patent Covering the Expanded Use of Kappa Opioid Receptor Agonist CR845 and Analogs for the Treatment and Prevention of Pain-Related Conditions
9:05AM ET on Tuesday Feb 10, 2015 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced the issuance of U.S. Patent No. 8,951,970 with claims covering the use of its lead clinical compound, CR845, and related compounds of this chemical class for the treatment and prevention of a broad range of pain-related conditions.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced the issu...

Cara Therapeutics Issued Additional U.S. Patent Covering Expanded Use of CR845 for Treatment and Prevention of Pain-Related Conditions; Shares Rise Pre-Market
8:36AM ET on Tuesday Feb 10, 2015 by Midnight Trader
Companies Mentioned: CARA
08:36 AM EST, 02/10/2015 (MT Newswires) -- Cara Therapeutics (CARA) said Tuesday it has been issued an additional U.S. patent covering the use of its lead clinical compound, CR845, and related compounds for the treatment and prevention of a broad ra...
08:36 AM EST, 02/10/2015 (MT Newswires) -- Cara Therapeutics (CARA) said Tuesday it has been issued an additional U.S. patent covering the use of its lead clinical compound, CR845, and related compounds for the treatment and prevention of a broad...

Peers Headlines

Yesterday

Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update
16 hours ago by PR Newswire
Companies Mentioned: PFNX

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and difficult to manufacture proteins, announced today that its fourth quarter and full year 2014 fi...

Mar 4, 2015

POZEN Announces March 9th Webcast of Fourth Quarter and Year End 2014 Results
7:30AM ET on Wednesday Mar 04, 2015 by Business Wire
Companies Mentioned: POZN

POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that it plans to release fourth quarter and year end 2014 results on March 9, 2015, before the ma...

Mar 2, 2015

Pfenex to Present at the 2015 Barclays Global Healthcare Conference
8:30AM ET on Monday Mar 02, 2015 by PR Newswire
Companies Mentioned: PFNX

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced that it will be presenting at the 2015 Barclays Global Healthcare Conference in Miami, FL at the Loews M...

Feb 27, 2015

Pfenex to Present at CALBIO 2015
8:00AM ET on Friday Feb 27, 2015 by PR Newswire
Companies Mentioned: PFNX

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced that it will be presenting at CALBIO 2015 at the San Francisco Marriott Marquis on March 2nd at 3pm PST....

Feb 19, 2015

Sector Update: Health Care Stocks Turn Higher At Close; Vanda Pharma Slides After Posting Wider-Than-Expected Q4 Net Loss
4:00PM ET on Thursday Feb 19, 2015 by Midnight Trader
Companies Mentioned: EPRS, VNDA, CSLT
04:00 PM EST, 02/19/2015 (MT Newswires) -- Top Health Care Stocks JNJ +0.82% PZE -0.36% MRK +0.43% ABT -0.71% AMGN +0.19% Health care stocks turned narrowly higher this afternoon with the NYSE Health Care Sector Index rising 0.1% and shares ...
Sector Update: Health Care
3:58PM ET on Thursday Feb 19, 2015 by Midnight Trader
Companies Mentioned: EPRS, VNDA, CSLT
03:58 PM EST, 02/19/2015 (MT Newswires) -- Health care stocks turned narrowly higher this afternoon with the NYSE Health Care Sector Index rising 0.1% and shares of health care companies in the S&P 500 also advancing about about 0.1% as a group. ...
Sector Update: Health Care Stocks Slightly Underwater; Healthstream Falling After Q4 Sales Miss Street View
2:15PM ET on Thursday Feb 19, 2015 by Midnight Trader
Companies Mentioned: HSTM, EPRS, CSLT
02:15 PM EST, 02/19/2015 (MT Newswires) -- Top Health Care Stocks JNJ +0.48% PZE -0.90% MRK -0.43% ABT -1.36% AMGN +0.12% Health care stocks were narrowly lower today with the NYSE Health Care Sector Index slipping 0.2% and shares of health ...
Sector Update: Health Care
2:15PM ET on Thursday Feb 19, 2015 by Midnight Trader
Companies Mentioned: HSTM, EPRS, CSLT
02:15 PM EST, 02/19/2015 (MT Newswires) -- Health care stocks were narrowly lower Thursday with the NYSE Health Care Sector Index slipping 0.2% and shares of health care companies in the S&P 500 falling about 0.1% as a group. In company news, Hea...
Analyst Actions: EPIRUS Biopharmaceuticals Up Nearly 8%; Wedbush Starts Coverage With Outperform Rating
1:47PM ET on Thursday Feb 19, 2015 by Midnight Trader
Companies Mentioned: EPRS
01:47 PM EST, 02/19/2015 (MT Newswires) -- EPIRUS Biopharmaceuticals (EPRS) shares gained nearly 8% Thursday after Wedbush started coverage with an outperform rating. Wdbush said the company's concentrated disease focus and strategy of striking ...

Feb 18, 2015

Analyst Actions: Pozen Initiated With Buy And $10 Price Target At Chardan Capital
2:46PM ET on Wednesday Feb 18, 2015 by Midnight Trader
Companies Mentioned: POZN
02:46 PM EST, 02/18/2015 (MT Newswires) -- Pozen (POZN) shares were initiated by Chardan Capital with a Buy rating and $10 price target. Price: 7.28, Change: +0.47, Percent Change: +6.90 ...
← Newer12Older →